Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Debt Ratio (2020)

Historic Debt Ratio for Vistagen Therapeutics (VTGN) over the last 4 years, with Q3 2020 value amounting to 0.0.

  • Vistagen Therapeutics' Debt Ratio changed N/A to 0.0 in Q3 2020 from the same period last year, while for Sep 2020 it was 0.0, marking a year-over-year change of. This contributed to the annual value of 0.0 for FY2013, which is N/A changed from last year.
  • As of Q3 2020, Vistagen Therapeutics' Debt Ratio stood at 0.0.
  • In the past 5 years, Vistagen Therapeutics' Debt Ratio registered a high of 0.02 during Q2 2020, and its lowest value of 0.0 during Q3 2020.